{"date":"2026-08-03","count":46,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6446-2026-08-03-2242-162lr2j","company_id":"6446","company":"藥華藥","market":"上市","industry":"生技醫療","date":"2026-08-03","time":"22:42:25","subject":"本公司及泛泰醫療子公司之部份資訊系統遭受駭客網路攻擊","clause":"第26款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：藥華藥（6446），2026-08-03 22:42，「本公司及泛泰醫療子公司之部份資訊系統遭受駭客網路攻擊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2026-08-03-2108-13evewo","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"21:08:22","subject":"本公司研發之用於上呼吸道給藥之組成物及其給藥方法(OBM-B01)獲台灣衛生福利部食品藥物管理署（TFDA）通知，同意進行第一期人體臨床試驗","clause":"第44款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2026-08-03 21:08，「本公司研發之用於上呼吸道給藥之組成物及其給藥方法(OBM-B01)獲台灣衛生福利部食品藥物管理署（TFDA）通知，同意進」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2026-08-03-2107-bpmxtk","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"21:07:00","subject":"本公司子公司普元生技自主開發之「邑普能」攜帶式噴霧器，獲得衛生福利部食品藥物管理署(TFDA)第二等級醫療器材許可證","clause":"第53款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-08-03 21:07，「本公司子公司普元生技自主開發之「邑普能」攜帶式噴霧器，獲得衛生福利部食品藥物管理署(TFDA)第二等級醫療器材許可證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-08-03-1847-37n2dy","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"18:47:26","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-08-03 18:47，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-08-03-1824-3p8kb9","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"18:24:41","subject":"公告本公司115年第一次現金增資收足股款暨訂定增資基準日","clause":"第44款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-08-03 18:24，「公告本公司115年第一次現金增資收足股款暨訂定增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-08-03-1823-1y0wdea","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"18:23:13","subject":"公告本公司經主管機關核准調整115年第一次現金增資發行股數暨補償方案及承諾書","clause":"第44款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-08-03 18:23，「公告本公司經主管機關核准調整115年第一次現金增資發行股數暨補償方案及承諾書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-08-03-1822-dc6jyq","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"18:22:47","subject":"公告本公司115年第二季財務報告董事會召開日期為115年8月11日","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-08-03 18:22，「公告本公司115年第二季財務報告董事會召開日期為115年8月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-08-03-1820-ri35y","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"18:20:12","subject":"公告本公司董事長變動事宜","clause":"第6款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-08-03 18:20，「公告本公司董事長變動事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6621-2026-08-03-1819-54swv6","company_id":"6621","company":"華宇藥","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"18:19:39","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：華宇藥（6621），2026-08-03 18:19，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-08-03-1810-1dyccx7","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"18:10:35","subject":"本公司受邀參加第一金證券舉辦之實體暨線上法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-08-03 18:10，「本公司受邀參加第一金證券舉辦之實體暨線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4737-2026-08-03-1756-9chkew","company_id":"4737","company":"華廣","market":"上市","industry":"生技醫療","date":"2026-08-03","time":"17:56:22","subject":"公告本公司115年第2季財務報告董事會預計召開日期為115年8月11日","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：華廣（4737），2026-08-03 17:56，「公告本公司115年第2季財務報告董事會預計召開日期為115年8月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-08-03-1755-1i4tty1","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-08-03","time":"17:55:38","subject":"公告本公司民國115年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-08-03 17:55，「公告本公司民國115年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6709-2026-08-03-1752-100esni","company_id":"6709","company":"昱厚生技","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"17:52:48","subject":"公告本公司研發主管異動","clause":"第11款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：昱厚生技（6709），2026-08-03 17:52，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-08-03-1747-1k40spg","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"17:47:04","subject":"公告本公司115年度第二季財務報告董事會預計召開日期為115年8月11日","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-08-03 17:47，「公告本公司115年度第二季財務報告董事會預計召開日期為115年8月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-08-03-1743-1gmnv9c","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-08-03","time":"17:43:06","subject":"本公司新藥CBL-514注射劑於中國一期臨床試驗CBL-0102向中國國家藥品監督管理局藥品審評中心(NMPA CDE)提出臨床試驗申請。","clause":"第10款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-08-03 17:43，「本公司新藥CBL-514注射劑於中國一期臨床試驗CBL-0102向中國國家藥品監督管理局藥品審評中心(NMPA CDE)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-08-03-1739-gif1qg","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"17:39:02","subject":"公告115年第2季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-08-03 17:39，「公告115年第2季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-08-03-1732-9gxzmk","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"17:32:36","subject":"公告本公司115年第二季合併財務報告董事會預計召開日期為115年8月12日","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-08-03 17:32，「公告本公司115年第二季合併財務報告董事會預計召開日期為115年8月12日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-08-03-1716-1tpjosz","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"17:16:45","subject":"公告本公司法人董事代表人辭任","clause":"第6款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-08-03 17:16，「公告本公司法人董事代表人辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-08-03-1715-1dbkp06","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"17:15:58","subject":"公告本公司董事長解任","clause":"第6款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-08-03 17:15，「公告本公司董事長解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-08-03-1715-oh1thc","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"17:15:03","subject":"公告本公司法人董事代表人改派","clause":"第6款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-08-03 17:15，「公告本公司法人董事代表人改派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2026-08-03-1705-131f9ff","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"17:05:03","subject":"代子公司宏碁健康股份有限公司公告董事會決議通過辦理現金增資發行新股案","clause":"第9款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2026-08-03 17:05，「代子公司宏碁健康股份有限公司公告董事會決議通過辦理現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2026-08-03-1704-p0cy0d","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"17:04:48","subject":"公告本公司董事會決議通過一一五年第二季合併財務報告","clause":"第43款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2026-08-03 17:04，「公告本公司董事會決議通過一一五年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-08-03-1650-xj4nq3","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-08-03","time":"16:50:22","subject":"公告本公司董事會決議115年第2季不辦理虧損撥補暨115年第2季不發放股利","clause":"第14款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-08-03 16:50，「公告本公司董事會決議115年第2季不辦理虧損撥補暨115年第2季不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-08-03-1645-dx22o7","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"16:45:28","subject":"公告本公司115年第二季合併財務報告董事會預計召開日期為115年8月11日","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-08-03 16:45，「公告本公司115年第二季合併財務報告董事會預計召開日期為115年8月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7726-2026-08-03-1636-s3fqjw","company_id":"7726","company":"暄達","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"16:36:24","subject":"公告本公司董事會決議通過115年第二季合併財務報告","clause":"第43款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：暄達（7726），2026-08-03 16:36，「公告本公司董事會決議通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-08-03-1629-1v332z0","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-08-03","time":"16:29:24","subject":"公告本公司115年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-08-03 16:29，「公告本公司115年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-08-03-1625-qjsdh2","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-08-03","time":"16:25:56","subject":"115年第2季財務報告董事會預計召開日期為115年08月11日","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-08-03 16:25，「115年第2季財務報告董事會預計召開日期為115年08月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-08-03-1617-37n2dy","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-08-03","time":"16:17:26","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-08-03 16:17，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-08-03-1617-k4sfzm","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"16:17:12","subject":"公告本公司董事會決議通過115年第二季合併財務報表","clause":"第43款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-08-03 16:17，「公告本公司董事會決議通過115年第二季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2026-08-03-1611-q7trls","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"16:11:19","subject":"公告本公司115年第二季財務報告董事會預計召開日期為115年08月11日","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：合世（1781），2026-08-03 16:11，「公告本公司115年第二季財務報告董事會預計召開日期為115年08月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2026-08-03-1609-l0uvpa","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"16:09:00","subject":"公告本公司115年第一次股東臨時會重要決議事項","clause":"第15款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2026-08-03 16:09，「公告本公司115年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2026-08-03-1607-112gndx","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"16:07:42","subject":"公告本公司董事會通過115年度第二季個別財務報告","clause":"第43款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2026-08-03 16:07，「公告本公司董事會通過115年度第二季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-08-03-1540-58p4oj","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"15:40:50","subject":"公告本公司115年第2季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-08-03 15:40，「公告本公司115年第2季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-08-03-1538-1szuhi6","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-03","time":"15:38:18","subject":"本公司法人董事指派代表人","clause":"第6款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-08-03 15:38，「本公司法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2026-08-03-1530-37n2dy","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"15:30:57","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2026-08-03 15:30，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2026-08-03-1526-1pfhp2q","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"15:26:05","subject":"公告本公司115年第2季財務報告董事會預計召開日期為115年08月11日","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2026-08-03 15:26，「公告本公司115年第2季財務報告董事會預計召開日期為115年08月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-08-03-1519-1bker2o","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"15:19:34","subject":"公告本公司115年第二季合併財務報告之董事會召開日期","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-08-03 15:19，「公告本公司115年第二季合併財務報告之董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-08-03-1511-4bdtmx","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"15:11:40","subject":"公告本公司更換股務代理機構","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-08-03 15:11，「公告本公司更換股務代理機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-08-03-1419-1v332z0","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-08-03","time":"14:19:46","subject":"公告本公司115年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-08-03 14:19，「公告本公司115年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-08-03-1410-1pfhp2q","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"14:10:34","subject":"公告本公司115年第2季財務報告董事會預計召開日期為115年08月11日","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-08-03 14:10，「公告本公司115年第2季財務報告董事會預計召開日期為115年08月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-08-03-1403-dx22o7","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"14:03:42","subject":"公告本公司115年第二季合併財務報告董事會預計召開日期為115年8月11日","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-08-03 14:03，「公告本公司115年第二季合併財務報告董事會預計召開日期為115年8月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2026-08-03-1353-1qijtki","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2026-08-03","time":"13:53:41","subject":"公告本公司115年第二季財務報告董事會預計召開日期為115年8月11日","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2026-08-03 13:53，「公告本公司115年第二季財務報告董事會預計召開日期為115年8月11日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2026-08-03-1330-1b9r7vd","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"13:30:07","subject":"公告本公司115年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2026-08-03 13:30，「公告本公司115年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-08-03-1104-1vcveq4","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-08-03","time":"11:04:09","subject":"澄清115年8月1日新聞媒體報導","clause":"第51款","fact_date":"2026-08-01","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-08-03 11:04，「澄清115年8月1日新聞媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-08-03-0808-1w9e9k8","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"08:08:03","subject":"本公司新世代 ADC 藥物 GNX1021正式啟動一期臨床試驗完成首位受試者收案","clause":"第53款","fact_date":"2026-08-03","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-08-03 08:08，「本公司新世代 ADC 藥物 GNX1021正式啟動一期臨床試驗完成首位受試者收案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-08-03-0006-1h9vnsa","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-08-03","time":"00:06:29","subject":"代孫公司江蘇華瀚醫藥科技有限公司公告HH-001沙庫巴曲纈沙坦鈉片藥品中選第十二批中國大陸集中採購名單","clause":"第53款","fact_date":"2026-07-31","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-08-03 00:06，「代孫公司江蘇華瀚醫藥科技有限公司公告HH-001沙庫巴曲纈沙坦鈉片藥品中選第十二批中國大陸集中採購名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}